Real-time enrollment status for this t acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 9:46 PM UTC
| NCT Number | NCT00501826 |
| Recruiting Status | Recruiting |
| Condition | T Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 160 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of September 3, 2026: Clinical trial NCT00501826 is currently recruiting participants. This phase2 study for t acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT00501826 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT00501826 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.